INSULIN GLARGINE clinical trials

Prospective study to assess with Continuous Glucose Monitoring (CGM) the efficacy and safety of switching to insulin glargine 300 U/ml from insulin glargine 100 U/ml in Type 2 Diabetes (T2DM) patients with renal impairment

This study looks at how a different strength of insulin glargine (a type of long-acting insulin) works for people with Type 2 diabetes and kidney problems. Researchers want to see if switching to the stronger insulin helps keep blood sugar levels stable and is safe.